These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 14980717

  • 1. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ, Peng Q, Fu P, Wang SW, Chiang CF, Dillehay DL, Wu MW.
    Gene; 2004 Mar 03; 327(2):201-13. PubMed ID: 14980717
    [Abstract] [Full Text] [Related]

  • 2. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
    Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.
    Gene; 2001 Nov 14; 279(1):17-31. PubMed ID: 11722842
    [Abstract] [Full Text] [Related]

  • 3. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
    Wu GJ, Fu P, Chiang CF, Huss WJ, Greenberg NM, Wu MW.
    J Urol; 2005 May 14; 173(5):1778-83. PubMed ID: 15821586
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M.
    Cancer Res; 1997 Jun 01; 57(11):2295-303. PubMed ID: 9187135
    [Abstract] [Full Text] [Related]

  • 8. METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells.
    Zeng G, Cai S, Liu Y, Wu GJ.
    Gene; 2012 Jan 15; 492(1):229-38. PubMed ID: 22057013
    [Abstract] [Full Text] [Related]

  • 9. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
    Wu GJ, Varma VA, Wu MW, Wang SW, Qu P, Yang H, Petros JA, Lim SD, Amin MB.
    Prostate; 2001 Sep 15; 48(4):305-15. PubMed ID: 11536311
    [Abstract] [Full Text] [Related]

  • 10. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L, Tellez C, Huang S, Baker C, McCarty M, Green L, Gudas JM, Feng X, Bar-Eli M.
    Cancer Res; 2002 Sep 01; 62(17):5106-14. PubMed ID: 12208768
    [Abstract] [Full Text] [Related]

  • 11. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 12. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ.
    Clin Cancer Res; 1996 Sep 01; 2(9):1627-36. PubMed ID: 9816342
    [Abstract] [Full Text] [Related]

  • 13. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
    Hall CL, Dai J, van Golen KL, Keller ET, Long MW.
    Cancer Res; 2006 Sep 01; 66(17):8648-54. PubMed ID: 16951179
    [Abstract] [Full Text] [Related]

  • 14. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.
    Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538
    [Abstract] [Full Text] [Related]

  • 15. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 16. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
    Singh LS, Berk M, Oates R, Zhao Z, Tan H, Jiang Y, Zhou A, Kirmani K, Steinmetz R, Lindner D, Xu Y.
    J Natl Cancer Inst; 2007 Sep 05; 99(17):1313-27. PubMed ID: 17728215
    [Abstract] [Full Text] [Related]

  • 17. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ, Ressler SJ, Larsen M, Tuxhorn JA, Yang F, Dang TD, Rowley DR.
    Cancer Res; 2003 Sep 15; 63(18):5859-65. PubMed ID: 14522910
    [Abstract] [Full Text] [Related]

  • 18. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
    Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C, Bonmassar E, Spano P.
    Clin Cancer Res; 1999 May 15; 5(5):1211-8. PubMed ID: 10353759
    [Abstract] [Full Text] [Related]

  • 19. Over-expression of CD9 does not affect in vivo tumorigenic or metastatic properties of human prostate cancer cells.
    Zvieriev V, Wang JC, Chevrette M.
    Biochem Biophys Res Commun; 2005 Nov 18; 337(2):498-504. PubMed ID: 16198313
    [Abstract] [Full Text] [Related]

  • 20. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR.
    Cancer Res; 2002 Jun 01; 62(11):3298-307. PubMed ID: 12036948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.